Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9541)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2014 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15079-15086 [PMID: 25386056 DOI: 10.3748/wjg.v20.i41.15079] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15079.htm |
| Number | Citing Articles |
| 1 |
Chengjun Wei, Hongxia Zhang, Chenghong Wei, Youyan Mao. Correlation of the expression of miR-146a in peripheral blood mononuclear cells of patients with ankylosing spondylitis and inflammatory factors. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5155
|
| 2 |
Amedeo Lonardo, Fabio Nascimbeni, Mauro Maurantonio, Alessandra Marrazzo, Luca Rinaldi, Luigi Elio Adinolfi. Nonalcoholic fatty liver disease: Evolving paradigms. World Journal of Gastroenterology 2017; 23(36): 6571-6592 doi: 10.3748/wjg.v23.i36.6571
|
| 3 |
Teresa Auguet, Gemma Aragonès, Alba Berlanga, Esther Guiu-Jurado, Andreu Martí, Salomé Martínez, Fàtima Sabench, Mercé Hernández, Carmen Aguilar, Joan Sirvent, Daniel Del Castillo, Cristóbal Richart. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2016; 17(10): 1620 doi: 10.3390/ijms17101620
|
| 4 |
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASH. Biomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
|
| 5 |
Hyun Yi Kook, So‐Hee Jin, Pu‐Reum Park, Seung‐Jin Lee, Hong‐Joon Shin, Tae‐Jong Kim. Serum miR‐214 as a novel biomarker for ankylosing spondylitis. International Journal of Rheumatic Diseases 2019; 22(7): 1196 doi: 10.1111/1756-185X.13475
|
| 6 |
Carla Bizzarri, Rita M. Pinto, Sara Ciccone, Letizia P. Brescia, Franco Locatelli, Marco Cappa. Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantation. Pediatric Blood & Cancer 2015; 62(9): 1650 doi: 10.1002/pbc.25603
|
| 7 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. International Journal of Molecular Sciences 2018; 19(12): 3966 doi: 10.3390/ijms19123966
|
| 8 |
Anurag Mishra, Adiba Nizam, Rajdeep Singh. Gallbladder Cancer. 2023; : 177 doi: 10.1007/978-981-19-6442-8_11
|
| 9 |
Rodica Talmaci. miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventions. Dietetician.ro 2023; 3(3): 18 doi: 10.26416/Diet.3.3.2023.8754
|
| 10 |
Henry Wade, Qiaozhu Su. Comprehensive Foodomics. 2021; : 398 doi: 10.1016/B978-0-08-100596-5.22723-6
|
| 11 |
Jooho Lee, Yuri Kim, Simonetta Friso, Sang-Woon Choi. Epigenetics in non-alcoholic fatty liver disease. Molecular Aspects of Medicine 2017; 54: 78 doi: 10.1016/j.mam.2016.11.008
|
| 12 |
Marica Meroni, Miriam Longo, Veronica Erconi, Luca Valenti, Stefano Gatti, Anna Ludovica Fracanzani, Paola Dongiovanni. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Nutrients 2019; 11(11): 2597 doi: 10.3390/nu11112597
|
| 13 |
Bruno de Souza Goncalves, Avery Meadows, Duane G. Pereira, Raghav Puri, Sneha S. Pillai. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. Biomedicines 2023; 11(6): 1597 doi: 10.3390/biomedicines11061597
|
| 14 |
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Annals of Hepatology 2021; 21: 100212 doi: 10.1016/j.aohep.2020.04.012
|
| 15 |
Fengqiong Liu, Qing Chen, Fa Chen, Jing Wang, Ruijie Gong, Baochang He. The lncRNA ENST00000608794 acts as a competing endogenous RNA to regulate PDK4 expression by sponging miR-15b-5p in dexamethasone induced steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(10): 1449 doi: 10.1016/j.bbalip.2019.07.003
|
| 16 |
Azahara I. Rupérez, Augusto Anguita-Ruiz. Obesity. 2018; : 17 doi: 10.1016/B978-0-12-812504-5.00002-7
|
| 17 |
Sabrina Campisano, Anabela La Colla, Stella M. Echarte, Andrea N. Chisari. Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases. Nutrition Research Reviews 2019; 32(1): 128 doi: 10.1017/S0954422418000239
|
| 18 |
Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 2021; 9(11): 1524 doi: 10.3390/biomedicines9111524
|
| 19 |
Vishal Chandra, Jong Joo Kim, Balraj Mittal, Rajani Rai. MicroRNA aberrations: An emerging field for gallbladder cancer management. World Journal of Gastroenterology 2016; 22(5): 1787-1799 doi: 10.3748/wjg.v22.i5.1787
|
| 20 |
Fernanda Torres Quitete, Ananda Vitória Silva Teixeira, Thamara Cherem Peixoto, Bruna Cadete Martins, Geórgia Correa Atella, Angela de Castro Resende, Daniela de Barros Mucci, Fabiane Martins, Julio Beltrame Daleprane, Partha Mukhopadhyay. Long-term exposure to polychlorinated biphenyl 126 induces liver fibrosis and upregulates miR-155 and miR-34a in C57BL/6 mice. PLOS ONE 2024; 19(8): e0308334 doi: 10.1371/journal.pone.0308334
|
| 21 |
Cheng Ma, Cheng Wang, Yafang Zhang, Honglin Zhou, Yunxia Li. Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic
Fatty Liver Disease: A Review on Molecular Mechanisms. Current Molecular Pharmacology 2022; 15(6): 846 doi: 10.2174/1874467215666211217120448
|
| 22 |
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae, Soheyla Khakdan. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 2020; 126(3): 242 doi: 10.1080/13813455.2018.1510968
|
| 23 |
Junjie Xiao, Dongchao Lv, Yingying Zhao, Xiaoyu Chen, Meiyi Song, Jingqi Liu, Yihua Bei, Fei Wang, Wenzhuo Yang, Changqing Yang. miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(8): 1603 doi: 10.1111/jcmm.12848
|
| 24 |
Li Su, Mingmei Liu. Correlation analysis on the expression levels of microRNA‑23a and microRNA‑23b and the incidence and prognosis of ovarian cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8669
|
| 25 |
Anıl Delik, Sadık Dinçer, Hikmet Akkız. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis. Meta Gene 2020; 24: 100647 doi: 10.1016/j.mgene.2020.100647
|
| 26 |
Mario Bartiromo, Michele Nardolillo, Serena Ferrara, Giuseppina Russo, Emanuele Miraglia Del Giudice, Anna Di Sessa. The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?. Expert Review of Gastroenterology & Hepatology 2023; 17(8): 817 doi: 10.1080/17474124.2023.2242245
|
| 27 |
Mona A Hegazy, Ibrahim Abd ALgwad, Soheir Abuel Fadl, Mohamed Sayed Hassan, Laila Ahmed Rashed, Maha A Hussein. Serum Micro-RNA-122 Level as a Simple Noninvasive Marker of MAFLD Severity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 2247 doi: 10.2147/DMSO.S291595
|
| 28 |
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect Binomium. International Journal of Molecular Sciences 2020; 21(8): 2986 doi: 10.3390/ijms21082986
|
| 29 |
Fatiha Nassir. NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules 2022; 12(6): 824 doi: 10.3390/biom12060824
|
| 30 |
Taruna Ahrodia, Bharti Kandiyal, Bhabatosh Das. Epigenetics in Health and Disease - Part B. Progress in Molecular Biology and Translational Science 2023; 198: 93 doi: 10.1016/bs.pmbts.2023.03.018
|
| 31 |
Dafei Xie, Peiwen Yuan, Dong Wang, Hua Jin, Hui Chen. Expression and prognostic significance of miR-375 and miR-221 in liver cancer. Oncology Letters 2017; 14(2): 2305 doi: 10.3892/ol.2017.6423
|
| 32 |
Alan Eduardo Botello-Manilla, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Genetics and epigenetics purpose in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2020; 14(8): 733 doi: 10.1080/17474124.2020.1780915
|
| 33 |
Bo Zhang, Haijun Li, Dongwei Li, Hongzhi Sun, Mingqiang Li, Huawen Hu. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. Gene 2019; 700: 139 doi: 10.1016/j.gene.2019.02.096
|
| 34 |
Hualin Wang, Yang Shao, Fahu Yuan, Han Feng, Na Li, Hongyu Zhang, Chaodong Wu, Zhiguo Liu. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/2503847
|
| 35 |
Yu-Tao Zhan, Hai-Ying Su, Wei An. Glycosyltransferases and non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(8): 2483-2493 doi: 10.3748/wjg.v22.i8.2483
|
| 36 |
Zhila Bahramirad, Mohammad Raman Moloudi, Mohammad Moradzad, Alina Abdollahi, Zakaria Vahabzadeh. Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10754-0
|
| 37 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes 2021; 9(1): 135 doi: 10.3390/pr9010135
|
| 38 |
Junjie Xiao, Yihua Bei, Jingqi Liu, Jasmina Dimitrova‐Shumkovska, Dapeng Kuang, Qiulian Zhou, Jin Li, Yanning Yang, Yang Xiang, Fei Wang, Changqing Yang, Wenzhuo Yang. miR‐212 downregulation contributes to the protective effect of exercise against non‐alcoholic fatty liver via targeting FGF‐21. Journal of Cellular and Molecular Medicine 2016; 20(2): 204 doi: 10.1111/jcmm.12733
|
| 39 |
Matthew Nayor, Svati H. Shah, Venkatesh Murthy, Ravi V. Shah. Molecular Aspects of Lifestyle and Environmental Effects in Patients With Diabetes. Journal of the American College of Cardiology 2021; 78(5): 481 doi: 10.1016/j.jacc.2021.02.070
|
| 40 |
Jinkyung Cho, Jinhwan Yoon, Inho Park, Hyunsik Kang. Effect of Training Intensity on Hepatic Steatosis and Expression of miRNAs and Target Genes in a High-fat Diet-induced Mice. Exercise Science 2018; 27(1): 32 doi: 10.15857/ksep.2018.27.1.32
|
| 41 |
Guan Wang, Haibo Zou, Chunyou Lai, Xiaolun Huang, Yutong Yao, Guangming Xiang. Repression of MicroRNA-124-3p Alleviates High-Fat Diet–Induced Hepatosteatosis by Targeting Pref-1. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.589994
|
| 42 |
Chao Sun, Jian-Gao Fan, Liang Qiao. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(3): 5161 doi: 10.3390/ijms16035161
|
| 43 |
György Baffy. MicroRNAs in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2015; 4(12): 1977 doi: 10.3390/jcm4121953
|
| 44 |
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
|
| 45 |
Prajakta C. Shimpi, Vijay R. More, Maneesha Paranjpe, Ajay C. Donepudi, Jaclyn M. Goodrich, Dana C. Dolinoy, Beverly Rubin, Angela L. Slitt. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environmental Health Perspectives 2017; 125(8) doi: 10.1289/EHP664
|
| 46 |
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1046497
|
| 47 |
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8): 1038 doi: 10.1016/j.metabol.2015.12.012
|
| 48 |
Jun-Ke Long, Wen Dai, Ya-Wen Zheng, Shui-Ping Zhao. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular Medicine 2019; 25(1) doi: 10.1186/s10020-019-0085-2
|
| 49 |
Fengqiong Liu, Ruijie Gong, Xiaofei Lv, Huangyuan Li. The expression profiling and ontology analysis of non-coding RNAs in dexamethasone induced steatosis in hepatoma cell. Gene 2018; 650: 19 doi: 10.1016/j.gene.2018.01.089
|
| 50 |
Yong-Hong Zhang, Heng-Li Xie, Yu-Wei Yang, Jie Wen, Ran-Ran Liu, Gui-Ping Zhao, Xiao-Dong Tan, Zhen Liu, Yi Zheng, Jia-Bao Zhang. miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ). Poultry Science 2023; 102(1): 102218 doi: 10.1016/j.psj.2022.102218
|
| 51 |
Lide Arenaza, María Medrano, María Amasene, Beatriz Rodríguez-Vigil, Ignacio Díez, Manuel Graña, Ignacio Tobalina, Edurne Maiz, Edurne Arteche, Eider Larrarte, Inge Huybrechts, Catherine L. Davis, Jonatan R. Ruiz, Francisco B. Ortega, Javier Margareto, Idoia Labayen. Prevention of diabetes in overweight/obese children through a family based intervention program including supervised exercise (PREDIKID project): study protocol for a randomized controlled trial. Trials 2017; 18(1) doi: 10.1186/s13063-017-2117-y
|